FDA Approves Humira Biosimilar Hadlima for Treatment of Ankylosing Spondylitis - Ankylosing Spondylitis News

FDA Approves Humira Biosimilar Hadlima for Treatment of Ankylosing Spondylitis  Ankylosing Spondylitis News

Hadlima (adalimumab-bwwd), a biosimilar to Humira, has been approved by the FDA for the treatment of ankylosing spondylitis.



Comments

Popular posts from this blog

Fibromyalgia — Latest Stories — Pain News Network

Chronic Lyme arthritis: A mystery solved?

Epstein-Barr virus and autoimmune diseases